Pazopanib-induced fatal heart failure in a patient with unresectable soft tissue sarcoma and review of literature.
Mustafa KaraağaçMelek Karakurt EryılmazPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)
Pazopanib-induced heart failure may be fatal. Physicians and patients should be aware of the cardiotoxicity risk when managing the use of pazopanib in soft tissue sarcoma.
Keyphrases
- heart failure
- end stage renal disease
- high glucose
- diabetic rats
- primary care
- chronic kidney disease
- ejection fraction
- drug induced
- left ventricular
- peritoneal dialysis
- metastatic renal cell carcinoma
- prognostic factors
- case report
- atrial fibrillation
- squamous cell carcinoma
- endothelial cells
- locally advanced
- radiation therapy
- acute heart failure